Budania A, Mandal S, Pathania YS, et al. - Researchers conducted the study for comparing the novel and conventional platelet‐rich plasma (PRP) in the treatment of periorbital hyperpigmentation. Twenty-one patients of periorbital hyperpigmentation were selected and randomly divided the face into two halves. One‐half of the face (group A) was treated with novel PRP (SS and low‐temperature activation), whereas the other half (group B) was treated with conventional PRP (DS and calcium activation). In total, 3 PRP injections were given at 4 weekly intervals. Data reported that the mean platelet count in novel and conventional PRP was 7.41 ± 1.76 lacs and 8.17 ± 2.23 lacs. At the end of the study, the mean photographic and dermoscopic assessment in group A and group B was 52.33 ± 6.468 and 53.14 ± 6.99, respectively. In the treatment of periorbital hyperpigmentation, the novel method is not inferior to the conventional PRP method.